Cantel Medical Corp. (CMD) Analysts See $0.60 EPS

May 17, 2018 - By Marie Mckinney

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.60 EPS on May, 31 before the open.They anticipate $0.09 EPS change or 17.65 % from last quarter’s $0.51 EPS. CMD’s profit would be $25.03M giving it 53.12 P/E if the $0.60 EPS is correct. After having $0.59 EPS previously, Cantel Medical Corp.’s analysts see 1.69 % EPS growth. The stock increased 2.07% or $2.59 during the last trading session, reaching $127.48. About 217,886 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 41.41% since May 17, 2017 and is uptrending. It has outperformed by 29.86% the S&P500.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $5.32 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 59.13 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Another recent and important Cantel Medical Corp. (NYSE:CMD) news was published by which published an article titled: “Jim Cramer Weighs In On Align Technology, Berkshire Hathaway, Symantec And More” on May 15, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.